相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons
Yasuhiko Izumi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats
Jessica Mendes Bonato et al.
EXPERIMENTAL NEUROLOGY (2018)
Synthesis of new heterocyclic compounds based on pyrazolopyridine scaffold and evaluation of their neuroprotective potential in MPP+-induced neurodegeneration
Jabrane Jouha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway
Ting-Ting Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells
Jianlei Zhang et al.
DISEASE MARKERS (2017)
Nrf2: a modulator of Parkinson's disease?
Michael Todorovic et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways
Wen-Ying Wei et al.
PPAR RESEARCH (2016)
Phytoestrogens modulate hepcidin expression by Nrf2: Implications for dietary control of iron absorption
Henry K. Bayele et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Tideglusib protects neural stem cells against NMDA receptor overactivation
Guliz Armagan et al.
PHARMACOLOGICAL REPORTS (2015)
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway
Mohammed Qaisiya et al.
CELLULAR SIGNALLING (2014)
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa et al.
MOVEMENT DISORDERS (2014)
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
Guenter U. Hoeglinger et al.
MOVEMENT DISORDERS (2014)
Primer3-new capabilities and interfaces
Andreas Untergasser et al.
NUCLEIC ACIDS RESEARCH (2012)
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease
C. Laloux et al.
PHARMACOLOGICAL RESEARCH (2012)
Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism
Agnieszka Jazwa et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
Christine R. Swanson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
Patricia Rada et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Deprenyl prevents MPP+-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K/Akt and Erk
Haibing Xiao et al.
TOXICOLOGY (2011)
Regulation of protein stability by GSK3 mediated phosphorylation
Chong Xu et al.
CELL CYCLE (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
Agnes Petit-Paitel et al.
PLOS ONE (2009)
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
Pei-Chun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease
Derek A. Drechsel et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Nrf2-induced antioxidant Protection: A Promising target to counteract ROS-mediated damage in neurodegenerative disease?
Helga E. de Vries et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Overexpression of Heme Oxygenase-1 Protects Dopaminergic Neurons against 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity
Shih-Ya Hung et al.
MOLECULAR PHARMACOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors
Gerhard Kroenke et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
GSK-3β acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2
Abhinav K. Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: Potential therapeutic role in brain disorders
Rosario Luna-Medina et al.
JOURNAL OF NEUROSCIENCE (2007)
Protective effect of sulforaphane against dopaminergic cell death
Ji Man Han et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
Cytoprotection by lithium and valproate varies between cell types and cellular stresses
Justin S. Lai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Glycogen synthase kinase-3β inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
Maria Salazar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A positive feedback loop between glycogen synthase kinase 3β and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons
E Szatmari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro
RJ Jakel et al.
TOXICOLOGICAL SCIENCES (2005)
Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor γ activation
R Luna-Medina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death
G Chen et al.
FASEB JOURNAL (2004)
Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult
AD Kraft et al.
JOURNAL OF NEUROSCIENCE (2004)
Inactivation of glycogen synthase kinase-3β protects against kainic acid-induced neurotoxicity in vivo
S Goodenough et al.
BRAIN RESEARCH (2004)
Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells
H Hara et al.
MOLECULAR BRAIN RESEARCH (2003)
Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity
L Facci et al.
NEUROREPORT (2003)
Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease
HJ Choi et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease
MS Yoo et al.
MOLECULAR BRAIN RESEARCH (2003)
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
A Martinez et al.
MEDICINAL RESEARCH REVIEWS (2002)
First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors:: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease
A Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Heme oxygenase-1: role in brain aging and neurodegeneration
HM Schipper
EXPERIMENTAL GERONTOLOGY (2000)
分享论文
